Introduction
AIDS-related mortality has decreased significantly with the wide availability of combination antiretroviral therapy (cART). Some people infected with human immunodeficiency virus type 1 who initiate cART soon after infection do not show HIV-1-specific antibodies or cellular responses, indicating the early control of viral replication [1] . An HIV-1 infection quickly establishes a latent reservoir primarily in the resting memory CD4
þ T-cells, and several factors could affect the size of this viral reservoir. With respect to these factors, it has been demonstrated that when cART is initiated earlier, the size of the proviral reservoir in the peripheral CD4 þ T cells in HIV-infected children [2e5] or adults [6] is smaller. In terms of host factors, a 32-base-pair deletion in one allele of the CCchemokine receptor (CCR5) gene decreases the surface expression of viral co-receptor. The CCR5 (WT/D32) genotype in HIV-infected individuals has been associated with lower pre-cART HIV-1 RNA levels and slower progression of HIV-1 disease in the absence of cART [7e9]; however, the impact of the CCR5 (WT/D32) genotype on the size of the latent HIV-1 reservoir is still controversial. Previous studies in adults recently infected with HIV-1 [10] or in children infected perinatally [11] , suggested that cell-associated HIV-1 DNA levels are lower in CCR5 (WT/D32) HIV-1-infected individuals compared with CCR5 (WT/WT) individuals. In contrast, a recently published study that involved a large cohort of HIV-1-infected CCR5 (WT/D32) adults on long-term suppressive cART did not show significant differences in cell-associated HIV-1 DNA and RNA levels [12] . Because perinatally HIV-infected individuals have been infected during the course of the maturation of their immune system, they present unique HIV-1 infection features. For instance, the memory T-cell population in the peripheral blood mononuclear cells (PBMC) is small in newborns [13] and develops later in childhood [14] . Memory CD4
þ T cells present in the newborn blood or gut are susceptible to HIV-1 infection [15] . Of note, the differential co-receptor surface expression on CD4 þ T-cell subsets [16] makes the memory (CD45RO þ ) CD4 þ T cells a significant viral reservoir for R5-tropic strains [17] , whereas X4-tropic strains are mainly present in naive (CD45RA þ ) CD4 þ T cells [18] . Moreover, perinatally HIV-1-infected patients have suffered a persistent chronic activation of their immune system throughout their lifetime, causing specific patterns of immunosenescence of CD4 þ Tcell subsets [19] . Therefore, it is worthwhile to elucidate how CCR5 (WT/D32) heterozygosity can affect the persistence of HIV-1 in perinatally HIVinfected patients with suppressed viraemia. We retrospectively studied a cohort of adolescents and young adults with perinatally acquired HIV-1 infections on suppressive cART. We evaluated the frequency of the CCR5 genotypes and studied the association of the CCR5 (WT/D32) genotype with the HIV-1 reservoir size, lymphocyte differentiation, activation and immunosenescence.
Methods

Study participants
The study included 242 participants with a vertically transmitted HIV-1 infection from the Paediatric Spanish AIDS Research Network Cohort (coRISpe). PBMC samples from each individual were subjected to CCR5 genotyping. To quantify proviral HIV-1 DNA, we sampled participants who had maintained viral suppression ( 200 HIV-1 RNA copies/mL) for at least 1 year with no treatment discontinuation and with available cryopreserved PBMC. Twenty-three out of 242 participants were heterozygous for the D32 genotype (CCR5 (WT/D32) ), and of these, ten fulfilled the selection criteria. Among the 219 participants homozygous for the wild-type CCR5 genotype (CCR5 (WT/WT) ), and after assessing the inability of having a perfect 1:1 matched study based on potential confounding effects, including hepatitis C virus co-infection, we finally selected 14 CCR5 (WT/WT) participants matched with the CCR5 (WT/D32) group by sex, age at virological control (± 1.5 years), and age at cART initiation (± 2.5 years). Cryopreserved plasma, PBMC and clinical data were provided by the Spanish HIV HGM BioBank [20] and by coRISpe.
The clinical classification of AIDS-defining events and immunological categories were based on international guidelines [21] . The Ethics Committee and Clinical Research of Hospital Gregorio Marañ on in Madrid approved this Delta 32-15-01 study.
CCR5 genotyping
DNA samples were obtained from the PBMC using the QIAamp Blood kit (Qiagen, Madrid, Spain). A portion of the CCR5 gene was amplified by PCR with primers that flanked the 32-bp deletion [22] . Wild-type and deleted fragments of 185 bp and 153 bp, respectively, were generated and visualized in 2% agarose gels. Heterozygosity (i.e. CCR5
(WT/D32) ) was indicated by the presence of both fragments.
Quantification of the proviral HIV-1 DNA
To evaluate the size of the proviral reservoir, CD4
þ peripheral T cells were purified from the cryopreserved PBMC by negative immunomagnetic separation (CD4 þ T-cell Isolation Kit; Miltenyi Biotech, Barcelona, Spain) (purity >90%). Lysed CD4 þ T-cell extracts were used to measure cell-associated total HIV-1 DNA through a droplet digital polymerase chain reaction, as previously described [5] .
Cellular immunophenotype
Isolated CD4 þ T cells were stained for 1 h at 4 C using the conjugated monoclonal antibodies CD45RO-phycoerythrin-Cy7 (Becton Dickinson, Madrid, Spain), (Phycoerythrincyanin 5.1) CD25-PC5 and (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride) CD45RA-ECD, CD57-FITC, CD28-phycoerythrin (Beckman Coulter, Madrid, Spain), CD38-allophycocyanin-Cy5.5 (Invitrogen, Madrid, Spain) and HLA-DR-allophycocyanin (Immunostep, Madrid, Spain). Naive (CD45RA þ ) and memory (CD45RO þ ) CD4 þ T-cell subsets were defined [23] . Cellular activation in CD4 þ T-cell subsets was characterized by CD25, CD38 and HLA-DR expression [24] . Senescent CD4 þ T cells were characterized as
At least 50 000 events were collected for each sample in a Gallios flow cytometer and analysed with the KALUZA software (Beckman-Coulter).
Determination of viral tropism
In samples taken near birth, viral tropism was determined by syncytium formation in MT-2 cells measured by a standard assay [25] , respectively, considering X4-tropic or R5-tropic isolates able or not able to form syncytia. Viral tropism at sampling was based on the ability of the cellfree virus to infect U87-CD4 þ CCR5 þ and U87-CD4 þ CXCR4 þ and was assayed with the previously described phenotypic HIV-1 tropism co-receptor assay information [26] .
Statistical analysis
We compared numerical and categorical variables between the two CCR5 genotype groups using the ManneWhitney U test and Fisher's exact test, respectively. Wilcoxon's signed-rank test was used for intragroup comparisons. Spearman's rank correlation coefficient was used to identify associations between the percentage of memory CD4
þ T-cells and cell-associated HIV-1 DNA levels.
Results
Cohort characteristics
The initial study population comprised 242 perinatally HIV-1-infected participants who were analysed for CCR5 genotypes, nadir CD4
þ T-cell counts, immunological and clinical categories (Table 1) . Of 242 HIV-1-infected participants, 219 (90.5%) were homozygous for the wild-type genotype, CCR5 (WT/WT) and 23 (9.5%)
were heterozygous for the D32 genotype, CCR5
(WT/D32) . We found no homozygosity for the mutated allele CCR5 (D32/D32) ( Table 1) . We observed no differences in the clinical and demographic characteristics of the two genotype groups, except for the ethnicity of the HIV-1-infected participants, which reflected the previously described higher frequency of the heterozygous CCR5 (WT/D32) allele genotype in participants of European ancestry [9, 27] .
Further analyses were performed on a subset of 24 HIV-1-infected participants of European ancestry (ten CCR5
(WT/D32) and 14 CCR5 (WT/WT) ). The selection criteria permitted the similarity of sex, age at virological control and age at cART initiation between the ten CCR5 (WT/D32) and 14 CCR5 (WT/WT) HIV-1 participants ( The association of CCR5 (WT/D32) heterozygosity with T-cell subsets and cell-associated HIV-1 DNA levels
As previously described for vertically HIV-infected adolescents [19] , the HIV-1-infected participants included in this study presented a highly preserved naive T-cell subset (42.5% and 35.8% of wanted to determine whether a difference in viral tropism existed between the two genotype groups that could discordantly affect the composition of the CD4 þ T-cell population. Contrary to expectations, viral tropism in samples obtained close to birth showed that the isolates from the CCR5 (WT/D32) participants were R5 tropic (i.e. non-syncytia inducing), whereas four out of ten isolates of the CCR5 (WT/WT) participants were X4-tropic (i.e. syncytia inducing) (Table 3) . Moreover, at sample collection, R5-tropic isolates were found in most of the CCR5 (WT/D32) participants but only in two participants with the CCR5 (WT/WT) genotype (Table 3 , and Fig. 2b,c) .
CCR5D32 heterozygosity association with T-cell activation and immunosenescence
Perinatally HIV-1-infected participants presented specific patterns of immunosenescence of CD4 þ T-cell subsets because their immune system had been chronically activated throughout their lifetime [19] . Moreover, the higher percentage of memory CD4 þ T cells found in CCR5 (WT/D32) HIV-1-infected participants could indicate a more profound immune exhaustion. Nevertheless, we found no significant differences between CCR5 (WT/D32) and CCR5 (WT/WT) participants with respect to CD25, CD38 or HLA-DR This cohort included Caucasians and gypsies, and the prevalence of the heterozygous allele was 9.5%, which is in agreement with previous studies that describe how the frequency of the CCR5 (WT/ D32) allele varies between ethnic groups. The prevalence of the heterozygous allele ranges from 0.6% among Asians to 20% among European Caucasians [9, 27] . The CCR5
(WT/D32) genotype did not affect parameters such as the zenith plasma viral load or nadir CD4 þ T cells. Although we did not find significant differences in the pattern of progression to clinical AIDS, we cannot discount a potential role for these genetic characteristics, because the sample size was limited. If CCR5 is the primary co-receptor used by HIV-1 to enter the target cell during the early stages of an HIV-1 infection, then it can be expected that heterozygous participants (CCR5 (WT/D32) ) may harbour a smaller proviral reservoir than homozygous participants (CCR5 (WT/WT) ). Previous studies suggested that cell-associated HIV-1 DNA levels are lower in CCR5 (WT/D32) individuals compared with CCR5 (WT/WT) -infected adults [10] . In contrast, data from a large cohort of HIV-1-infected CCR5 (WT/D32) adults on long-term suppressive cART revealed no significant differences in the cellassociated HIV-1 DNA and RNA levels or in the frequency of detectable RNA and 2-LTR circles [12] . Sei et al. [11] found lower cell-associated HIV-1 DNA in CCR5 (WT/D32) perinatally infected children younger than 5 years old compared with CCR5 (WT/WT) , but no significant differences in proviral burden were present in those examined after 5 years of age. In accordance with that study, our results for viral reservoir size in CD4 þ T cells also showed no difference between CCR5 (WT/WT) and CCR5 (WT/D32) ( Fig. 1 ) in perinatally HIV-1-infected adolescents (median age 18.7 years; interquartile range 15.5e19.9). Nevertheless, we cannot exclude differences in the viral reservoir size in other non-blood compartments, such as gut-associated lymphoid tissues. Additionally, in agreement with the previously mentioned studies [11, 12] , we found no significant differences between the two genotype groups in terms of CD4 Table S1 ). Intriguingly, the significant difference in the percentage between naive and memory CD4 þ T cells (Fig. 2a) found in CCR5
(WT/ WT) individuals and also previously observed in perinatally HIV-1-infected children [19] was not present in the CCR5 (Fig. 2b) . Nevertheless, HIV-1-infected participants with a CCR5 (WT/D32) genotype seem to present a direct correlation (Fig. 2c) . These data may suggest differential cell targeting depending on the CCR5 genotype: memory CD4 þ T cells in CCR5 (WT/WT) participants and naive CD4 þ T cells in
subsets have different co-receptors expressed on the cell surface [16] , so naive CD4 þ T cells are a significant viral reservoir for X4-tropic strains [18] , whereas R5-tropic strains are mainly present in memory CD4 þ T cells [17] . Therefore, to elucidate the reason for this differential cell targeting, it was necessary to determine the viral tropism of the HIV-1 isolates in each individual. At first glance, tropism in participants close to birth failed to confirm this hypothesis, as all isolates from the CCR5 (WT/D32) HIV-1-infected participants were R5 tropic, whereas four of ten isolates from CCR5
(WT/ WT) were X4-tropic (Table 3) . Moreover, at sample collection, R5-tropic isolates were found in most of the CCR5 (WT/D32) individuals but in only two with the CCR5 (WT/WT) genotype (Table 3 and Fig. 2b,c) . This preferential evolution towards X4-tropism in CCR5 (WT/WT) participants was in accordance with previous studies that reported a high prevalence of X4-or dual mix-tropic viruses in perinatally HIV-1-infected participants [26] and a correlation between this high prevalence and the switch from R5 to X4-tropic viruses due to the long-term exposure to HIV-1 infection [29] . In contrast, all the isolates from the CCR5 (WT/D32) individuals remained purely R5-tropic. It may be possible that during the course of the disease, R5 viruses evolve towards a more efficient usage of CCR5 that favours an increased ability to infect target cells with a low surface density of CCR5 [30] The restricted sample amounts limit the quantitative determination of the surface CCR5 density in each cell subpopulation, but CCR5 cell-surface density could be a determining factor in future studies to explain the differential targeting of the cell subsets. Another limitation of this study was the use of two different techniques to determine viral tropism. The reason is partly due to the time interval between birth and sample collection, considering the median age of the individuals from our study is 18.7 years. Nevertheless, both techniques are phenotypic assays with good concordance between them as well as with the widely accepted Trofile assay.
In summary, the CCR5 genotype did not affect the HIV-1 reservoir size in CD4 þ T cells in the perinatally HIV-infected adolescent and young adult cohort studied, but a correlation was evident between the total HIV-1 DNA in CD4 þ T cells and the percentage of memory CD4 þ T cells, which was direct in CCR5 (WT/D32) participants and inverse in those with the CCR5 (WT/WT) genotype. Although the underlying mechanism remains to be elucidated, the differential cell targeting observed in HIV-1-infected youngsters with the CCR5 (WT/D32) genotype could cause a change in the reservoir cell compartment. Therefore, it might be important to design different strategies for the elimination of the viral reservoir according to the CCR5 genotype. 
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